ZIKV-envelope proteins induce specific humoral and cellular immunity in distinct mice strains
Open Access
- 21 September 2022
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-13
Abstract
Recent outbreaks of Zika virus (ZIKV) infection have highlighted the need for a better understanding of ZIKV-specific immune responses. The ZIKV envelope glycoprotein (EZIKV) is the most abundant protein on the virus surface and it is the main target of the protective immune response. EZIKV protein contains the central domain (EDI), a dimerization domain containing the fusion peptide (EDII), and a domain that binds to the cell surface receptor (EDIII). In this study, we performed a systematic comparison of the specific immune response induced by different EZIKV recombinant proteins (EZIKV, EDI/IIZIKV or EDIIIZIKV) in two mice strains. Immunization induced high titers of E-specific antibodies which recognized ZIKV-infected cells and neutralized the virus. Furthermore, immunization with EZIKV, EDI/IIZIKV and EDIIIZIKV proteins induced specific IFNγ-producing cells and polyfunctional CD4+ and CD8+ T cells. Finally, we identified 4 peptides present in the envelope protein (E1–20, E51–70, E351–370 and E361–380), capable of inducing a cellular immune response to the H-2Kd and H-2Kb haplotypes. In summary, our work provides a detailed assessment of the immune responses induced after immunization with different regions of the ZIKV envelope protein.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (Grant 2018/05320-7, 2017/17471-7, 2021/13004-0)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)/Instituto de Investigação em Imunologia (grant 465434/2014-2)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Finance Code 001)
This publication has 61 references indexed in Scilit:
- Immunodominant T-cell responses to dengue virus NS3 are associated with DHFProceedings of the National Academy of Sciences, 2010
- The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing ActivityCell Host & Microbe, 2010
- The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell ResponseThe Journal of Immunology, 2009
- Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibodyVirology, 2009
- Humoral Immune Responses of Dengue Fever Patients Using Epitope-Specific Serotype-2 Virus-Like Particle AntigensPLOS ONE, 2009
- Yellow fever vaccine induces integrated multilineage and polyfunctional immune responsesJournal of Experimental Medicine, 2008
- Optimizing peptide matrices for identifying T‐cell antigensCytometry Part A, 2008
- Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain IIJournal of Virology, 2008
- Induction of Epitope-Specific Neutralizing Antibodies against West Nile VirusJournal of Virology, 2007
- Prospects for a dengue virus vaccineNature Reviews Microbiology, 2007